CompletedNot Applicable

Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia

Pakistan122 participantsStarted 2025-02-18

Plain-language summary

Postpartum anemia is a common condition associated with adverse maternal outcomes. This study aimed to compare the effectiveness of oral iron therapy versus intravenous iron therapy in women with postpartum anemia.

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. All women with postpartum anaemia as per operational definition i.e Haemoglobin \<11 g/dl at 24 hours after delivery (either caesarean or SVD).
✓. Age 20-40 years.
✓. BMI 19-25.
✓. Pre-operative haemoglobin \>10 g/dl.
✓. Both primiparous and multiparous.
✓. Both primigravida and multigravida.

Exclusion criteria

✕. Iron Intolerance or previous history of allergy to iron
✕. Parenteral Iron hypersensitivity
✕. Patients with thalassemia
✕. Indication of blood transfusion
✕. Patients with bleeding/ clotting disorders
✕. Patients with postpartum haemorrhage
✕. Patients with chronic diseases.

What they're measuring

Change in hemoglobin level

Timeframe: Baseline to 6 weeks postpartum

Trial details

NCT IDNCT07340450

SponsorShahida Islam Medical Complex

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-18

View on ClinicalTrials.gov More Postpartum Anaemia trials